BioVector? 人牙囊干細(xì)胞說(shuō)明書(shū)

BioVector? Human Dental Follicle Stem Cells (hDFSCs) Manual

第一部分 中文說(shuō)明

一 產(chǎn)品基本信息與生物學(xué)背景

• 細(xì)胞名稱：人牙囊干細(xì)胞（Human Dental Follicle Stem Cells, hDFSCs）。

• 物種來(lái)源：人源（Human），通常分離自正畸需要拔除的年輕患者（如 12-18 歲）健康阻生智齒（第三磨牙）外周包裹的牙囊組織。

• 核心生物學(xué)特性：

  • 外胚層間充質(zhì)干細(xì)胞（ECT-MSCs）：牙囊是包繞在發(fā)育中牙胚外周的疏松結(jié)締組織囊，來(lái)源于顱神經(jīng)嵴外胚間充質(zhì)。hDFSCs 屬于外胚層來(lái)源的間充質(zhì)干細(xì)胞，不僅具備傳統(tǒng)間充質(zhì)干細(xì)胞（MSCs）的自我更新和多向分化潛能，還保留了神經(jīng)外胚層的部分分化特性。

  • 免疫表型特征：根據(jù)國(guó)際細(xì)胞治療協(xié)會(huì)（ISCT）標(biāo)準(zhǔn)，hDFSCs 穩(wěn)定高表達(dá)間充質(zhì)干細(xì)胞表面標(biāo)志物（如 CD73, CD90, CD105, CD29, CD44），同時(shí)高度表達(dá)胚胎干細(xì)胞及外胚層標(biāo)志物（如 Stro-1, Notch-1, Nestin）；而造血干細(xì)胞及內(nèi)皮標(biāo)志物（如 CD34, CD45, CD11b, HLA-DR）表達(dá)呈嚴(yán)格陰性。

  • 多向分化潛能：在特定的體外誘導(dǎo)條件下，hDFSCs 能夠高效向成牙骨質(zhì)細(xì)胞（Cementoblasts）、成骨細(xì)胞（Osteoblasts）、成牙本質(zhì)細(xì)胞（Odontoblasts）分化，且具備跨生殖層向神經(jīng)樣細(xì)胞（Neurogenic cells）和脂肪細(xì)胞分化的能力。

• 生長(zhǎng)特性：貼壁生長(zhǎng)（Adherent），主要呈現(xiàn)長(zhǎng)梭形、成纖維細(xì)胞樣（Fibroblast-like）的集落狀（CFU-F）生長(zhǎng)形態(tài)。

• 生物安全級(jí)別：1級(jí)（BSL-1）。細(xì)胞已通過(guò)嚴(yán)格的支原體、原蟲(chóng)、細(xì)菌、真菌及人類(lèi)核心病毒（HIV, HBV, HCV）篩查，結(jié)果均為陰性。

二 核心科研價(jià)值與轉(zhuǎn)化醫(yī)學(xué)應(yīng)用

人牙囊干細(xì)胞被公認(rèn)為牙齒再生醫(yī)學(xué)及組織工程領(lǐng)域中最具潛力的“種子細(xì)胞”之一：

1. 牙周組織再生與功能性生物牙根構(gòu)建：牙囊在體內(nèi)原本就是牙周組織（牙骨質(zhì)、牙周膜和牙槽骨）的發(fā)育前體。hDFSCs 是目前體外研究牙骨質(zhì)再生、牙周膜（PDL）重塑以及構(gòu)建功能性成形生物牙根（Biomimetic Root）的核心細(xì)胞模型。

2. 顱面部骨缺損修復(fù)修復(fù)（Bone Tissue Engineering）：hDFSCs 的成骨分化能力極強(qiáng)，常與各類(lèi)生物相容性支架材料（如膠原、羥基磷灰石 HA、聚乳酸等）結(jié)合，用于研究體外頜骨缺森重建以及干細(xì)胞-材料交互動(dòng)力學(xué)。

3. 神經(jīng)再生與神經(jīng)退行性疾病研究：由于其特有的神經(jīng)嵴來(lái)源背景，hDFSCs 在受到神經(jīng)誘導(dǎo)時(shí)能快速上調(diào) Nestin、Tuj1 和 GFAP 的表達(dá)。常用于體外研究軸突導(dǎo)向、神經(jīng)保護(hù)作用以及周?chē)窠?jīng)損傷修復(fù)的細(xì)胞治療模型。

三 實(shí)驗(yàn)室細(xì)胞復(fù)蘇、擴(kuò)增傳代與冷凍保存標(biāo)準(zhǔn)步驟

1. 完全培養(yǎng)基配置（Complete Growth Medium）

hDFSCs 屬于對(duì)生長(zhǎng)因子需求較高的原代及有限傳代干細(xì)胞，建議配置如下高營(yíng)養(yǎng)體系：

• 基礎(chǔ)培養(yǎng)基：alpha-MEM（推薦） 或 DMEM/F12（含低糖）。

• 完全添加劑成分：

  • 10% - 15% 優(yōu)質(zhì)優(yōu)質(zhì)胎牛血清（FBS，建議選擇干細(xì)胞專(zhuān)屬級(jí)別）。

  • 1% 滅菌雙抗（Penicillin-Streptomycin）。

  • 任選添加劑：部分原代早期培養(yǎng)為了加速擴(kuò)增，可添加 2-4 mM L-谷氨酰胺及 1% 非必需氨基酸（NEAA），但常規(guī)培養(yǎng)上述配方已足夠。

2. 細(xì)胞復(fù)蘇（Thawing Protocol）

1. 將完全培養(yǎng)基放入 37攝氏度 水浴中預(yù)熱。

2. 從液氮罐中取出 hDFSCs 凍存管，立即投入 37攝氏度 恒溫水浴箱中，輕微晃動(dòng)。

3. 在 1 分鐘內(nèi)令其急速融化（至僅剩極小冰芯時(shí)撈出）。迅速用酒精擦拭外部。

4. 在生物安全柜內(nèi)，用移液管將細(xì)胞懸液吸出，置于含有 5-8 mL 預(yù)熱完全培養(yǎng)基的 15 mL 離心管中，極其輕柔地顛倒混勻，以稀釋 DMSO 濃度。

5. 以 200-300 x g 離心 3-5 分鐘，小心吸除含有 DMSO 的上清液。

6. 加入 3-5 mL 新鮮完全培養(yǎng)基，用移液槍極輕柔地吹打 1-2 次使細(xì)胞重懸（嚴(yán)禁劇烈震蕩導(dǎo)致剛復(fù)蘇的干細(xì)胞機(jī)械損傷）。接種于培養(yǎng)瓶中，置于 37攝氏度、5% CO2 孵箱中培養(yǎng)。

3. 細(xì)胞傳代（Passaging / Subculture）

• 傳代時(shí)機(jī)：切勿讓干細(xì)胞長(zhǎng)至 100% 完全融合。當(dāng)細(xì)胞密度達(dá)到約 80% - 85% 融合度時(shí)必須執(zhí)行傳代。干細(xì)胞過(guò)密會(huì)導(dǎo)致接觸抑制，引發(fā)自發(fā)性分化或喪失干性。

• 傳代步驟：

  1. 吸除舊培養(yǎng)基，用無(wú)菌 PBS（不含鈣鎂離子）輕輕洗滌細(xì)胞表面 1-2 次。

  2. 加入適量 0.25% Trypsin-EDTA 消化液（一般 T25 瓶加 1-1.5 mL），確保覆蓋細(xì)胞。

  3. 置于 37攝氏度 孵箱中消化 1 至 3 分鐘。在顯微鏡下觀察，當(dāng)大塊的長(zhǎng)梭形細(xì)胞變圓并開(kāi)始收縮、部分脫離瓶壁時(shí)，立即加入 2 倍體積的含血清完全培養(yǎng)基終止消化。

  4. 用移液槍輕柔吹打瓶壁，使貼壁細(xì)胞完全脫落。將細(xì)胞懸液收集至離心管中，300 x g 離心 3 分鐘，棄上清。

  5. 按照 1:2 至 1:3 的傳代比例接種到新的培養(yǎng)瓶/皿中。注：原代間充質(zhì)干細(xì)胞傳代比例不宜過(guò)稀，以保持細(xì)胞間的信號(hào)通訊。

4. 細(xì)胞冷凍保存（Cryopreservation）

• 凍存液配方：55% 基礎(chǔ)培養(yǎng)基 + 40% 優(yōu)質(zhì)胎牛血清（FBS） + 5% DMSO；或采用 90% FBS + 10% DMSO。推薦使用市售無(wú)血清的高效專(zhuān)用干細(xì)胞凍存液以維持極高的復(fù)蘇活率。

• 凍存操作：收集處于對(duì)數(shù)生長(zhǎng)活躍期（傳代代數(shù)通常控制在 P3-P6 之間最佳）的健康細(xì)胞，離心棄上清。調(diào)整細(xì)胞密度至 $\ge 1 \times 10^6$ cells/vial。加入凍存液重懸分裝后，立即投入標(biāo)準(zhǔn)程序降溫盒（異丙醇梯度降溫盒，1攝氏度/min），置于 -80攝氏度 過(guò)夜，次日必須轉(zhuǎn)移至 -196攝氏度 液氮中長(zhǎng)期冷凍保存。

Part 2 English Section

I General Information and Biological Background

• Cell Line Name: Human Dental Follicle Stem Cells (hDFSCs).

• Species Origin: Human. Isolated from healthy loose connective tissue of the dental follicle encapsulating impacted third molars (wisdom teeth), typically harvested during routine orthodontic extractions from adolescent patients (aged 12–18 years).

• Core Biological Framework:

  • Ectomesenchymal Stem Cell Lineage: The dental follicle is a specialized ectomesenchymal tissue derived from the cranial neural crest during odontogenesis. Belonging to the ectomesenchymal category, hDFSCs retain conventional mesenchymal stem cell (MSC) properties coupled with neural crest-derived developmental plasticity.

  • Immunophenotypic Profile: In alignment with the International Society for Cellular Therapy (ISCT) consensus, hDFSCs consistently exhibit high expressions of MSC surface markers (CD73, CD90, CD105, CD29, CD44) and prominent neural crest/embryonic stem signs (Stro-1, Notch-1, Nestin). Conversely, hematopoietic and endothelial markers (such as CD34, CD45, CD11b, and HLA-DR) are strictly negative.

  • Multi-lineage Differentiation Plasticity: Under tailored biochemical induction parameters in vitro, hDFSCs can easily commit to lineage-specific pathways yielding cementoblasts, osteoblasts, and odontoblasts, alongside cross-germline potential into neurogenic cells and adipocytes.

• Growth Topology: Adherent growth mode. Displays typical spindle-shaped, elongated, fibroblast-like morphologies exhibiting prominent Colony-Forming Unit-Fibroblast (CFU-F) clustering traits.

• Biosafety Matrix: Biosafety Level 1 (BSL-1). Rigorously authenticated and pre-screened negative for mycoplasma, protozoa, bacterial/fungal pathobionts, and core human viral indicators (HIV, HBV, HCV).

II Strategic Research Value & Translational Fields

Human dental follicle stem cells are widely recognized as choice seed cell matrices in structural tooth organ engineering and general regenerative medicine:

1. Periodontal Regeneration and Bio-Root Fabrication: In vivo, the dental follicle naturally yields the definitive components of the periodontium (cementum, periodontal ligament [PDL], and alveolar bone). In vitro, hDFSCs serve as a premier platform to examine cementogenesis, physiological PDL shearing integration, and functional biomimetic dental root tissue morphogenesis.

2. Craniofacial Bone Tissue Engineering: Benefiting from their vigorous osteogenic capabilities, hDFSCs are regularly integrated with complex biocompatible matrices (such as collagen, hydroxyapatite [HA], and PLA scaffolds) to model maxillo-mandibular bone reconstruction and dissect stem cell-material interfacial kinetics.

3. Neurogenesis & Neurodegenerative Therapy: Owing to their neural crest ontogeny, hDFSCs rapidly upgrade Nestin, Tuj1, and GFAP expression patterns under neurogenic induction. They provide a viable human-derived somatic model to explore axonal guidance, local neuroprotection, and peripheral nerve injury cell-based therapeutics.

III Thawing, Proliferation, Passaging, and Cryopreservation Routines

1. Formulating the Complete Growth Medium

As primary and low-passage progenitor lines sensitive to growth factor exhaustion, hDFSCs thrive optimally within highly enriched nutritional parameters:

• Basal Medium: alpha-MEM (Highly Recommended) or low-glucose DMEM/F12 alternative.

• Complete Media Supplements:

  • 10% to 15% Premium Fetal Bovine Serum (FBS, Stem-Cell Qualified Grade Preferred).

  • 1% Penicillin-Streptomycin cocktail.

  • Optional Additives: Early primary expansions may include 2–4 mM L-glutamine and 1% Non-Essential Amino Acids (NEAA) to accelerate log-phase velocity; however, standard cultivation runs efficiently within the core formula noted above.

2. Cryovial Thawing Routine

1. Pre-warm the formulated complete growth medium within a 37 degree Celsius water bath.

2. Retrieve the hDFSCs cryovial from liquid nitrogen storage and instantly submerge it into the 37 degree Celsius water bath with continuous gentle agitation.

3. Complete the thawing cycle rapidly within 1 minute (extract when a minute ice core remains). Swab the exterior thoroughly with 70% ethanol.

4. In a biosafety cabinet, transfer the cell slurry into a sterile 15 mL conical tube pre-filled with 5–8 mL of pre-warmed complete growth medium. Mix by gentle inversion to cushion osmotic pressure variations caused by liquefied DMSO.

5. Centrifuge the suspension at 200–300 x g for 3–5 minutes, then aspirate the DMSO-contaminated supernatant.

6. Replenish with 3–5 mL of fresh complete medium, and gently pipette up and down 1–2 times to re-suspend the pellet. Do not vortex or aggressively pipette to avoid mechanical shearing of vulnerable thawed cells. Plate into culture vessels and incubate at 37 degree Celsius under a humidified 5% CO2 atmosphere.

3. Subculturing and Cell Passaging Guide

• Confluency Threshold: Do not allow the cultures to reach 100% complete confluency. Execute passaging promptly when the monolayer strikes 80%–85% confluency. Over-crowding triggers contact inhibition, causing spontaneous lineage differentiation or irreversible loss of stemness features.

• Step-by-Step Harvesting:

  1. Aspirate the spent culture medium and gently wash the layer 1–2 times with sterile, calcium/magnesium-free PBS.

  2. Dispense an adequate volume of 0.25% Trypsin-EDTA Solution across the cell matrix (approx. 1–1.5 mL for standard T25 flasks).

  3. Incubate at 37 degree Celsius for 1 to 3 minutes. Monitor under an inverted microscope; as soon as the elongated spindle cells round up, shrink, and begin separating from the baseline matrix, immediately add a double volume of serum-containing complete growth medium to quench the enzyme.

  4. Resuspend the layer by gentle pipetting to dislodge remaining cells. Transfer the slurry to a conical tube and centrifuge at 300 x g for 3 minutes, then discard the supernatant.

  5. Re-plate into fresh flasks at a standard split ratio of 1:2 to 1:3. Note: Avoid plating primary MSCs at over-diluted ratios to preserve essential local paracrine signaling loops.

4. Cryopreservation Protocol

• Freezing Medium Matrix: 55% Basal Medium + 40% FBS + 5% DMSO, or 90% FBS + 10% DMSO. Alternatively, deploy validated protein-free commercial cryopreservation configurations for stem cells to maximize post-thaw recovery parameters.

• Freezing Routine: Harvest healthy cells strictly during their log-growth window (optimally utilizing passages P3 to P6). Spin down, discard the supernatant, and adjust the cell density to $\ge 1 \times 10^6$ viable cells/vial. Aliquot into cryovials and instantly place inside a standardized isopropyl alcohol controlled-rate freezing container. Store at -80 degree Celsius overnight, and relocate the tubes into liquid nitrogen (-196 degree Celsius) the following day for indefinite preservation.

BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心

電話:400-800-2947

工作QQ/微信同號(hào):1843439339

網(wǎng)址http://www.nedfriskphoto.com